Calyxo

CalyxoCalyxo
Calyxo

Calyxo

Redefining kidney stone treatment with an aspiration-based stone removal system.

DR 262016ActivePleasanton, USA
Rate

About

Calyxo, Inc. is a medical device company focused on revolutionizing the treatment of kidney stones. Their flagship product, the CVAC System, is an all-in-one aspiration-based system designed for efficient and effective stone removal. The company has achieved a significant milestone with 40,000 patients treated using their innovative technology, indicating growing clinical adoption.
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Calyxo do?

Calyxo, Inc. is a medical device company focused on revolutionizing the treatment of kidney stones. Their flagship product, the CVAC System, is an all-in-one aspiration-based system designed for efficient and effective stone removal. The company has achieved a significant milestone with 40,000 patients treated using their innovative technology, indicating growing clinical adoption.

How much funding has Calyxo raised?

Calyxo has raised a total of $151M in funding. The most recent round on record is Series F.

Where is Calyxo headquartered?

Calyxo is headquartered in Pleasanton, California, USA.

When was Calyxo founded?

Calyxo was founded in 2016.

What industry does Calyxo operate in?

Calyxo operates in Medical Devices, HealthTech, Biotechnology, MedTech, Surgical Robotics, Urology.

What is Calyxo's revenue?

StartupHub estimates Calyxo's annual revenue at $13.3M (range $5.7M to $53.7M, 29% confidence), based on comparable companies in the sector.

What is Calyxo's valuation?

StartupHub estimates Calyxo's effective valuation at $2.2B (range $1.6B to $3.5B, 55% confidence), based on comparable companies in the sector.